Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Arcutis Biotherapeutics Inc (ARQT)
Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 663,361
  • Shares Outstanding, K 61,083
  • Annual Sales, $ 3,690 K
  • Annual Income, $ -311,460 K
  • 60-Month Beta 0.52
  • Price/Sales 191.57
  • Price/Cash Flow N/A
  • Price/Book 3.36
Trade ARQT with:

Options Overview Details

View History
  • Implied Volatility 72.69% ( -7.64%)
  • Historical Volatility 46.22%
  • IV Percentile 35%
  • IV Rank 48.58%
  • IV High 109.12% on 10/18/22
  • IV Low 38.28% on 12/08/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 210
  • Volume Avg (30-Day) 498
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 6,857
  • Open Int (30-Day) 8,388

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.27
  • Growth Rate Est. (year over year) +78,761.42%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.65 +1.97%
on 03/15/23
17.57 -38.18%
on 03/01/23
-5.01 (-31.57%)
since 02/22/23
3-Month
10.65 +1.97%
on 03/15/23
17.57 -38.18%
on 03/01/23
-3.39 (-23.79%)
since 12/22/22
52-Week
10.65 +1.97%
on 03/15/23
27.40 -60.36%
on 08/31/22
-6.91 (-38.89%)
since 03/22/22

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Arcutis Biotherapeutics Inc. is late-stage biopharmaceutical company. It is focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases. The company's product pipeline consists of ARQ-151, ARQ-154 and ARQ-252 for multiple indications, including psoriasis,...

See More

Key Turning Points

3rd Resistance Point 12.13
2nd Resistance Point 11.86
1st Resistance Point 11.36
Last Price 10.86
1st Support Level 10.59
2nd Support Level 10.32
3rd Support Level 9.82

See More

52-Week High 27.40
Fibonacci 61.8% 21.00
Fibonacci 50% 19.02
Fibonacci 38.2% 17.05
Last Price 10.86
52-Week Low 10.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar